Associate Professor, Psychiatry, Perelman School of Medicine
Dr. Audrain-McGovern is a Professor in the Department of Psychiatry at the University of Pennsylvania (UPENN), a member of the Abramson Cancer Center, and a Senior Fellow in the Leonard Davis Institute for Health Economics and the Center for Health Incentives and Behavioral Economics. She received her Ph.D. in clinical psychology at the University of Memphis, completed her pre-doctoral clinical internship at Brown University, and spent the beginning of her academic career as a faculty member in the Departments of Psychiatry and Oncology at Georgetown University Medical Center.
Dr. Audrain-McGovern joined the faculty at UPENN in 2001, where she continued her tobacco research. Her epidemiological research focuses on identifying and understanding the bio-behavioral determinants of adolescent smoking acquisition, the relationship between adolescent e-cigarette use and subsequent combustible cigarette smoking, and pathways to dual use of tobacco products. Dr. Audrain-McGovern’s human laboratory research has focused on identifying novel smoking cessation treatment targets and understanding the abuse liability of tobacco flavoring using behavioral economic paradigms. Dr. Audrain-McGovern’s clinical trial research involves using behavioral economic informed interventions to target multiple co-occurring behaviors such as promoting smoking cessation while minimizing post-cessation increases in food intake.
Dr. Audrain-McGovern has been awarded 13 NIH grants as Principal Investigator, resulting in almost 140 peer-reviewed publications. She has served as the Director of the Training and Career Development Core for three P50 center grants focused on nicotine and tobacco research as well as the Co-Director of the Training and Career Enhancement Core for two Tobacco Centers for Regulatory Science at UPENN. She has served as an Associate Editor for Nicotine & Tobacco Research and Tobacco Regulatory Science, a program chair for the Society for Research on Nicotine and Tobacco, and has served on numerous NIH study sections.